AMBEE PHARMACEUTICALS PLC |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 719.9 BDT | +7.50% |
|
+0.19% | -11.73% |
| Sales 2022 | 181M 1.65M 132M | Sales 2023 | 198M 1.8M 144M | Capitalization | 1.32B 11.98M 959M |
|---|---|---|---|---|---|
| Net income 2022 | 8M 72.74K 5.82M | Net income 2023 | 9M 81.84K 6.55M | EV / Sales 2022 | 8.77 x |
| Net Debt 2022 | 328M 2.98M 239M | Net Debt 2023 | 364M 3.31M 265M | EV / Sales 2023 | 8.49 x |
| P/E ratio 2022 |
156
x | P/E ratio 2023 |
145
x | Employees | 477 |
| Yield 2022 |
0.19% | Yield 2023 |
0.27% | Free-Float | 22.75% |
More Fundamentals
* Assessed data
More news
| 1 day | +7.50% | ||
| 1 week | +0.19% | ||
| Current month | -5.88% | ||
| 1 month | -6.47% | ||
| 3 months | -11.05% | ||
| 6 months | -37.60% | ||
| Current year | -11.73% |
1 week
650.00
730.00
1 month
650.00790.00
Current year
650.00850.00
1 year
510.001 302.30
3 years
375.301 302.30
5 years
353.001 302.30
10 years
232.331 302.30
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | - | |
| Chairman | - | - | |
| Director/Board Member | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/04/24 | 719.9 | +7.50% | 4,659 |
| 24/04/24 | 669.7 | -4.64% | 2,017 |
| 23/04/24 | 702.3 | -0.82% | 1,261 |
| 22/04/24 | 708.1 | -0.27% | 1,935 |
| 21/04/24 | 710 | -1.18% | 1,785 |
End-of-day quote Dhaka S.E., April 24, 2024
More quotes
Ambee Pharmaceuticals Limited is a Bangladesh-based company, which is engaged in pharmaceutical operations. The principal activities of the Company are to manufacture, buy, sell, export, or otherwise deal in all kinds of drugs, medicines, pharmaceuticals, chemicals, medical or any other preparations and to refine, manipulate, or treat all such substances used in pharmaceutical industry and to do all such acts necessary in connection with any business or chemist druggist, chemical and medicine manufactures, pharmacists, and others. Its products include ANTAC, AMBEECLOX, STOMACID, FLUXIN, MYCEF, A-ROX, MYZID, HIFLOX, HIFLOX-XR, LEXLO, TETRAM, DOXILLIN, TACTIN, NALIDEX, AFLUZOLE, KLION, AFUVIN, TRIBEN-DS, AMETROL-VT, MESPA, SURAL, TRIBEN, AMINOPHYLLINE, CODEX, NILKOF, DEXTROMETHORPHAN, AMBEECAL, ACES PLUS, CALCITATE, C-BON, AMBEECAL D, CALCIUM AMBEE, VITEX, FOLAC, VITEX GOLD, AROLAK, HITFLAM, NAPROXIN, FUNGAKIL, FUNGAKIL, CINON, NOSTIS, AMASON, NOCTIN, DIPHEDAN, DOPEGYT and others.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -11.73% | 15.74M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- AMBEEPHA Stock
